Recruiting Interventional Study to Evaluate the Combination of Palbociclib + Sunitinib as a Treatment for Advanced Solid Tumors NCT06940349 Conditions Solid Tumors Refractory to Standard Therapy Locations Davidoff cancer center, RMC — Petah Tikva, Israel View Trial Details
Recruiting AD1208 in Subjects With Any Progressive, Locally Advanced or Metastatic Solid Tumors NCT06911333 Conditions Neoplasms, Solid Tumor, Solid Tumor Cancer, +5 more Locations Seoul National University Bundang Hospital — Seongnam-si, Gyeonggi-do, South Korea Severance Hospital — Seoul, South Korea Samsung Medical Center — Seoul, South Korea View Trial Details
Recruiting A Phase I Study of LXP1788 Injection with Advanced Solid Tumors. NCT06883539 Conditions Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +31 more Locations China Medical University Hospital — Taichung, Taiwan National Cheng Kung University Hospital — Tainan, Taiwan View Trial Details
Completed Kanglaite Injection Phase I Study NCT00031031 Conditions Neoplasms, Solid Tumors Refractory to Standard Therapy Locations Huntsman Cancer Institue — Salt Lake City, Utah, United States View Trial Details
